Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Sopheon Terug naar discussie overzicht

Sopheon juni 2022

11 Posts
| Omlaag ↓
  1. marblesthegame 6 juni 2022 19:37
    Sopheon PLC Issue of Equity & TVR

    Sopheon PLC

    06 June 2022

    For immediate release

    SOPHEON PLC

    ("Sopheon" or the "Company")

    Issue of Equity

    Sopheon, the international provider of software and services for Enterprise Innovation Management solutions, announces that, following the exercise of options by a former employee, it has allotted 10,000 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 10 June 2022.

    The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,620,104. The Company does not hold any shares in treasury. Accordingly, the figure of 10,620,104 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
  2. Tritace 10 juni 2022 10:10
    Strong start to another year of progress
    Sopheon’s AGM Statement, issued today, provides a reflection upon a busy FY2021 and looks forward to what has already started as a year of progress in FY2022. In FY2021, Sopheon grew recognised revenues and annual recurring revenues by 15%, beating market expectations in the process. The year also saw a new CEO and a reinforcement of the management team, along with the acquisition of ROI Blueprints. FY2022 appears to have started well, with six new customer wins (all SaaS based) already, compared with 10 in all of FY2021, and with the acquisition of Solverboard, announced in May. We are leaving our forecasts unchanged and continue to be impressed by Sopheon’s expansion and SaaS transition as management grows a more substantial business with greater long-term revenue visibility.

    The SaaS transition is a short-term
    drag on profitability and the market might appear to be overly penalising
    the company for following what is the correct long-term path. We urge
    investors to look ahead to where Sopheon is now clearly heading
  3. Gartje 12 juni 2022 07:29
    Nee niet verkocht! En tja wat kan je verwachten in deze tijd. Oorlog, stijgende prijzen, en veel onzekerheid! Dus was de outlook voor mij een reden ze gewoon op de plank te laten liggen.
    Zodra er rust komt in de wereld en alles weer gaat normaliseren zal de koers weer gaan stijgen. Het sentiment is negatief.
  4. marblesthegame 12 juni 2022 09:35
    quote:

    Gartje schreef op 12 juni 2022 07:29:

    Nee niet verkocht! En tja wat kan je verwachten in deze tijd. Oorlog, stijgende prijzen, en veel onzekerheid! Dus was de outlook voor mij een reden ze gewoon op de plank te laten liggen.
    Zodra er rust komt in de wereld en alles weer gaat normaliseren zal de koers weer gaan stijgen. Het sentiment is negatief.
    Ook niets verkocht.

    Er staan 10.620.104 aandelen uit.
    7.501.217 zijn van sopheon bestuurders en grote aandeelhouders
    Blijven er ruim 3 miljoen over, waarvan de meeste in handen zijn van partijen die onder de meldingsplicht blijven.
11 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.286
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.463
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.956
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.489
Aedifica 2 832
Aegon 3.257 320.093
AFC Ajax 537 7.018
Affimed NV 2 5.762
ageas 5.843 109.779
Agfa-Gevaert 13 1.862
Ahold 3.536 73.983
Air France - KLM 1.024 34.348
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.774
Alfen 12 16.550
Allfunds Group 3 1.217
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 337
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.767
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.368
AMG 965 125.873
AMS 3 73
Amsterdam Commodities 303 6.522
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.163
Apollo Alternative Assets 1 17
Apple 5 316
Arcadis 251 8.623
Arcelor Mittal 2.024 318.668
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.113
Aroundtown SA 1 176
Arrowhead Research 5 9.283
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.704
ASML 1.762 77.060
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.674
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 06 mei

    1. China inkoopmanagersindex diensten april
    2. PostNL Q1-cijfers
    3. Siemens Healthineers Q1-cijfers
    4. TKH Q1-cijfers
    5. Dui inkoopmanagersindex diensten april (def)
    6. EU inkoopmanagersindex diensten april (def) 52,9
    7. VK inkoopmanagersindex diensten april (def)
    8. EU producentenprijzen maart
    9. Tyson Foods Q1-cijfers
  2. 07 mei

    1. Japan inkoopmanagersindex diensten april
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht